Press release

Siemens Healthineers introduces most comprehensive ultrasound portfolio refresh

European Congress of Radiology (ECR), July 13-17, 2022

Published on 14. Juli 2022

1

AI-Software application leveraging machine learning-based Artificial Intelligence to achieve the intended outcome.

2

These products are not commercially available in all countries and/or all modalities. Their future availability cannot be guaranteed.

3

Datas on file, as of July 13, 2022.

Siemens Healthineers 2022

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com.